WO2021131720A1 - 油中水型乳化皮膚化粧料 - Google Patents
油中水型乳化皮膚化粧料 Download PDFInfo
- Publication number
- WO2021131720A1 WO2021131720A1 PCT/JP2020/045950 JP2020045950W WO2021131720A1 WO 2021131720 A1 WO2021131720 A1 WO 2021131720A1 JP 2020045950 W JP2020045950 W JP 2020045950W WO 2021131720 A1 WO2021131720 A1 WO 2021131720A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- group
- cosmetic
- oil
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to a water-in-oil emulsified skin cosmetic. More specifically, it is a water-in-oil emulsified skin cosmetic containing an ultraviolet protective agent. By contact with water such as water and sweat, the ultraviolet protective effect is improved compared to immediately after application, and the feeling of use is also improved. Regarding excellent water-in-oil emulsified skin cosmetics.
- Sunscreen cosmetics which are a type of UV care cosmetics, absorb UVA and UVB in the sun's rays by covering the skin with a coating film containing an ultraviolet absorber or an ultraviolet scattering agent. It is a cosmetic intended to protect the skin from the adverse effects of ultraviolet rays by suppressing the amount of ultraviolet rays that are scattered and reach the skin (Non-Patent Document 1).
- Sunscreen cosmetics applied to the skin are exposed to various moisture such as sweat and seawater secreted from the skin, so UV absorbers and UV scatterers flow out from the cosmetic coating applied to the skin, causing UV rays. It is inevitable that the protective effect will decrease. Therefore, a water-in-oil emulsified cosmetic is preferably used because of its excellent water resistance.
- Patent Document 1 a sunscreen cosmetic containing an ultraviolet protective agent is blended with an oil phase thickener or the like so that the coating film of the cosmetic comes into contact with water such as water or sweat.
- an oil phase thickener or the like so that the coating film of the cosmetic comes into contact with water such as water or sweat.
- the UV protection effect is improved as compared with immediately after application of the cosmetic (before contact with moisture).
- the cosmetic of Patent Document 1 is prepared as a water-in-oil emulsified cosmetic, the viscosity of the outer phase increases due to the addition of the oil phase thickener, which tends to cause stickiness. Therefore, further improvement has been required especially in terms of usability.
- the present invention provides a water-in-oil emulsified skin cosmetic having a property that the ultraviolet protection effect is improved as compared with immediately after application by coming into contact with water such as water or sweat, and also has an excellent usability.
- the purpose is.
- the present invention (A) At least one selected from (a-1) a copolymer having a silanol group and an oxypropylene group (PO) or an oxyethylene group (EO), and (a-2) a silylated peptide; and (B). ) Provide a water-in-oil emulsified skin cosmetic containing a UV protective agent.
- the water-in-oil emulsified skin cosmetic of the present invention has a significantly improved UV protection ability after contact with water, sweat, etc., as compared with immediately after the cosmetic is applied to the skin. Further, since the ultraviolet protection ability is sufficiently improved by the component (A) of the present invention, it is possible to reduce the amount of the oil phase thickener that has been conventionally added for the purpose of improving the ultraviolet protection ability, and it is sticky. It is possible to obtain a water-in-oil emulsified sunscreen cosmetic with excellent usability.
- the water-in-oil emulsified skin cosmetic of the present invention (hereinafter, may be simply referred to as “cosmetics”) is (A) Copolymer having (a-1) silanol group and oxypropylene group (PO) or oxyethylene group (EO) and / or (a-2) silylated peptide, and (B) It is characterized by containing an ultraviolet protective agent as an essential component.
- Cosmetics is (A) Copolymer having (a-1) silanol group and oxypropylene group (PO) or oxyethylene group (EO) and / or (a-2) silylated peptide, and (B) It is characterized by containing an ultraviolet protective agent as an essential component.
- the component (A) of the present invention is at least selected from a copolymer having (a-1) silanol group and an oxypropylene group (PO) or an oxyethylene group (EO), and (a-2) a silylated peptide. It is a kind.
- the cosmetic of the present invention may contain only one of (a-1) or (a-2), or may contain both (a-1) and (a-2). ..
- the copolymer having a (a-1) silanol group and an oxypropylene group (PO) or an oxyethylene group (EO), which is blended in the cosmetic of the present invention, has a polysiloxane structure and a polyoxyalkylene in the main chain of the polymer.
- a copolymer having a structure and having a side chain having a trialkoxysilane group or a silanol group hereinafter, abbreviated as "crosslinked silicone POA copolymer”).
- the polysiloxane structure constituting the main chain of the (a-1) crosslinked silicone POA copolymer of the present invention is composed of polydialkylsiloxane, preferably polydimethylsiloxane, and a part of the alkyl group (preferably methyl group) is phenyl. It may be substituted with a group.
- the polyoxyalkylene structure constituting the main chain of the (a-1) crosslinked silicone POA copolymer of the present invention is composed of oxyethylene groups (EO), oxypropylene groups (PO), and oxybutylene (BO) as repeating units. It is preferable that it contains at least one selected from the group.
- the (a-1) crosslinked silicone POA copolymer in the present invention preferably further has a side chain composed of an organic group.
- the organic group to be the side chain is a hydrocarbon group (preferably an alkyl group, for example, a straight chain having about 1 to 30 carbon atoms) which may be optionally substituted with a substituent such as an amino group, a hydroxyl group and a carboxyl group. (Like or branched alkyl group, phenyl group, etc.) can be mentioned.
- the hydrocarbon group preferably has an amino group, and the hydrogen atom of the amino group may be further substituted with an alkyl group or the like.
- the (a-1) crosslinked silicone POA copolymer of the present invention preferably further contains a nitrogen atom in its main chain, and preferably has the side chain bonded to the nitrogen atom.
- a more specific example of the crosslinked silicone POA copolymer is Polysilicone-29 (INCI name).
- Polysilicone-29 is defined as a composite silicone compound obtained by the reaction of a dimethylsiloxane polymer with a glycidoxypropyl group at the end with PEG-13 diglycidyl ether, diethylaminopropylamine and aminopropyltriisopropoxysilane. ..
- the (a-1) crosslinked silicone POA copolymer in the cosmetic of the present invention a commercially available product may be used.
- "Silsoft CLX-E” manufactured by Momentive Performance Materials
- this copolymer is a compound belonging to "Polysilicone-29”.
- the copolymer contains a polysiloxane structure, a polyoxyalkylene structure, and a nitrogen atom in the main chain, has a side chain having a trialkoxysilane group and a side chain consisting of an organic group, and the polysiloxane structure is polydimethylsiloxane or polyoxyalkylene.
- the structure contains polyoxyethylene and polyoxyisopropylene, and has a structure in which the side chain is bonded to the nitrogen atom of the main chain.
- "Silsoft CLX-E” is a product containing the copolymer, dipropylene glycol and water.
- the peptide represented by the general formula (I) is preferably used as the (a-2) silylated peptide to be blended in the cosmetic of the present invention.
- R 1 , R 2 , and R 3 represent alkyl groups or hydroxyl groups having 1 to 3 carbon atoms, and these R 1 , R 2 , and R 3 may all be the same or different.
- R 4 indicates a residue excluding the terminal amino group of a basic amino acid having an amino group at the end of the side chain
- R 5 indicates an amino acid side chain other than R 4
- a is 1 or 3
- m is 0 to 0 to 200 and n are 0 to 200
- m + n is 1 to 200.
- the silylated peptide (a-2) represented by the general formula (I) is, for example, The following general formula (II): [In formula (II), R 6 , R 7 , and R 8 represent an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a hydroxyl group, or a halogen atom, and these R 6 , R 7 , and R 8 all may be the same or may be different. a indicates 1 or 3.
- R 4 is a residue excluding the terminal amino group of a basic amino acid having an amino group at the end of the side chain, as described above.
- the basic amino acid having an amino group at the end of the side chain include lysine, arginine, and hydroxylysine.
- R 5 indicates a side chain of amino acids other than R 4 , and examples of such amino acids include glutamic acid, aspartic acid, alanine, serine, threonine, valine, methionine, leucine, isoleucine, tyrosine, phenylalanine, and proline. , Hydroxyproline and the like.
- the peptides represented by the above general formula (III) include amino acids, peptides, amino acids or esters of peptides.
- the above amino acids include alanine, glycine, valine, leucine, isoleucine, proline, phenylalanine, tyrosine, serine, threonine, methionine, arginine, histidine, lysine, aspartic acid, aspartic acid, glutamine, glutamic acid, cystine, cysteine, cysteine acid, Examples thereof include tryptophan, hydroxyproline, hydroxylysine, O-phosphoserine and cystine.
- the above-mentioned peptide is a natural peptide, a synthetic peptide, a hydrolyzed peptide obtained by partially hydrolyzing a protein with an acid, an alkali or an enzyme.
- the natural peptide include glutathione, bacitracin A, insulin, glucagon, oxytocin, vasopressin and the like
- the synthetic peptide include polyglycine, polylysine, polyglutamic acid and polyserine.
- the hydrolyzed peptide is a peptide obtained by partially hydrolyzing a protein with an acid, an alkali, an enzyme, or a combination thereof, and as the protein source thereof, an animal protein, a plant protein, and a protein derived from a microorganism.
- animal proteins include egg yolk proteins and egg white proteins such as silk, collagen (including gelatin which is a modified product thereof), keratin, fibroin, sericin, casein, conchiolin, elastin, protamine, and chicken.
- vegetable proteins include proteins contained in soybeans, wheat, rice (rice bran), sesame seeds, pea, corn, potatoes and the like.
- yeasts of the genus Saccharomyces, Candida, and Endomicopsis yeast proteins isolated from yeasts called brewer's yeast and sake yeast, and proteins isolated from mushrooms (basidiomycetes) and chlorella. And so on.
- ester of the amino acid or peptide examples include esters with hydrocarbon alcohols having 1 to 20 carbon atoms in the carboxyl group of the amino acids or peptides, for example, methyl esters, ethyl esters, propyl esters, isopropyl esters, lauryl esters, and cetyl esters. Examples thereof include 2-ethylhexyl ester, 2-hexyldecyl ester and stearyl ester.
- silylated peptide More specific examples of the silylated peptide include, for example, N- [2-hydroxy-3- (3-trihydroxysilyl) propoxy] propyl hydrolyzate protein, N- [2-hydroxy-3). -(3-Dihydroxymethylsilyl) propoxy] Propyl hydrolyzate protein and the like.
- (a-2) silylated peptide in the cosmetic of the present invention a commercially available product may be used.
- “Promois S-700SIG”, “Promois W-52SIG”, “Promois WS-HSIG” (all manufactured by Seiwa Kasei Co., Ltd.) and the like can be mentioned, and “Promois S-700SIG” is preferably used.
- “Promois S-700SIG” is a product containing (dihydroxymethylsilylpropoxy) hydroxypropyl hydrolyzed silk, 1,3-butylene glycol, methylparaben, propylparaben, and water.
- the blending amount of the component (A) in the cosmetic of the present invention is not particularly limited, but is preferably 0.08 to 2% by mass, more preferably 0.08 to 2% by mass, based on the pure content of the component (A). It is 0.15 to 1.5% by mass. If it is less than 0.08% by mass, the effect of improving the ultraviolet protection ability is not sufficient, and if it exceeds 2% by mass, stickiness tends to occur.
- the (B) UV protective agent (hereinafter, may be simply referred to as "ingredient (B)") blended in the cosmetic of the present invention means a UV absorber and / or a UV scattering agent, and is a sunscreen cosmetic. Those usually blended in can be used.
- ultraviolet absorber examples include benzoic acid derivatives, salicylic acid derivatives, silicic acid derivatives, dibenzoylmethane derivatives, ⁇ , ⁇ -diphenylacrylate derivatives, benzophenone derivatives, benzilidenshonow derivatives, phenylbenzoimidazole derivatives, triazine derivatives, and phenylbenzotriazoles.
- Derivatives, anthranil derivatives, imidazoline derivatives, benzalmalonate derivatives, 4,4-diarylbutadiene derivatives and the like are exemplified. Specific examples and product names are listed below, but the present invention is not limited to these.
- benzoic acid derivative examples include para-aminobenzoic acid (PABA) ethyl, ethyl-dihydroxypropyl PABA, ethylhexyl-dimethyl PABA (for example, "Escalol 5 ethylhexyl P25"; BASF), and diethylaminohydroxybenzoyl hexyl benzoate (for example, "" Ubinal A Plus ”) and the like are exemplified.
- PABA para-aminobenzoic acid
- ethyl ethyl-dihydroxypropyl PABA
- diethylaminohydroxybenzoyl hexyl benzoate for example, "" Ubinal A Plus
- Salicylic acid derivatives include homosalate (“Eusolex HMS”; Lona / EM Industries), ethylhexyl salicylate or octyl salicylate (eg, “NeoHeliopan OS”; Harman & Reimer), Examples include dipropylene glycol salicylate (eg, "Dipsal”; Skell), TEA salicylate (eg, "Neo Heliopan TS”; Harman and Reimer).
- Examples of the silicic acid derivative include octylmethoxycinnamate or ethylhexyl methoxycinnamate (eg, "Pulsol MCX”; Hoffmann-La Roche), isopropyl methoxycinnamate, isoamyl methoxycinnamate (eg, "Neo Heliopan E1000”; Herman. And Reimer), cinnoxate, DEA methoxycinnamate, diisopropyl methylsilicate, glyceryl-ethylhexanoate-dimethoxycinnamate, di- (2-ethylhexyl) -4'-methoxybenzalmalonate and the like.
- octylmethoxycinnamate or ethylhexyl methoxycinnamate eg, "Pulsol MCX”; Hoffmann-La Roche
- isopropyl methoxycinnamate iso
- dibenzoylmethane derivative examples include 4-tert-butyl-4'-methoxydibenzoylmethane (for example, "Pulsol 1789").
- ⁇ , ⁇ -diphenylacrylate derivatives examples include octocrylene (for example, “Ubinal N539T”; BASF).
- Benzophenone derivatives include benzophenone-1 (eg, "Ubinal 400"; BASF), benzophenone-2 (eg, “Ubinal D50”; BASF), benzophenone-3 or oxybenzone (eg, "Ubinal M40”; BASF), benzophenone.
- -4 eg, "Ubinal MS40”; BASF
- Benzophenone-5 Benzophenone-6 (eg, "Helisorb 11"; Norquay)
- Benzophenone-8 eg, "Spectra-Sorb” UV- 24 ”; American Cyanamide
- Benzophenone-9 eg,“ Ubinal DS-49 ”; BASF
- Benzophenone-12 and the like are exemplified.
- benzylidene camphor derivative examples include 3-benzylidene camphor (for example, "Mexoryl SD”; Simex), 4-methylbenzylidene camphor, benzylidene camphor sulfonic acid (for example, "Megizolyl SL”; Simex), and benzyl benzylco.
- Examples include nium (eg, "Megisolyl SO”; Simex), terephthalilidene camphor sulfonic acid (eg, "Megizolyl SX”; Simex), polyacrylamide methylbenzylidene camphor (eg, "Megisolyl SW”; Simex), and the like. ..
- phenylbenzimidazole derivative examples include phenylbenzimidazole sulfonic acid (for example, “Usolex 232"; Merck), disodium phenyldibenzoimidazole tetrasulfonate (for example, "Neo Heliopan AP”; Herman & Reimer). Illustrated.
- triazine derivatives examples include bisethylhexyloxyphenol methoxyphenyl triazine (for example, “Tinosorb S”; Ciba Specialty Chemicals), ethylhexyltriazone (for example, “Ubinal T150”; BASF), and diethylhexylbutamidtri.
- Azone eg, "Uvasorb HEB”; Sigma 3V
- 2,4,6-tris diisobutyl-4'-aminobenzalmaronate
- -s-triazine 2,4,6-tris [4] -(2-Ethylhexyloxycarbonyl) anilino] -1,3,5-triazine and the like are exemplified.
- Phenylbenzotriazole derivatives include drometrizoletrisiloxane (eg, "Silatrizole”; Rhodia Shimmy), methylenebis (benzotriazolyltetramethylbutylphenol) (eg, "Tinosorb M” (Ciba Specialty). Chemicals)), etc. are exemplified.
- anthranil derivative examples include menthyl anthranilate (for example, “Neo Heliopan MA”; Harman & Reimer).
- imidazoline derivative examples include ethylhexyldimethoxybenzylidene-dioxoimidazolin propionate.
- benzalmalonate derivative examples include polyorganosiloxane having a benzalmalonate functional group (for example, polysilicone-15; "Pulsol SLX”; DSM Nutrition Japan Co., Ltd.).
- 4,4-diarylbutadiene derivative examples include 1,1-dicarboxy (2,2'-dimethylpropyl) -4,4-diphenylbutadiene.
- the ultraviolet scattering agent used in the present invention is not particularly limited, and specific examples thereof include fine particle metal oxides such as zinc oxide, titanium oxide, iron oxide, cerium oxide, and tungsten oxide.
- the ultraviolet scattering agent may be one without surface treatment or one with various hydrophobic surface treatments, but those with hydrophobic surface treatment are preferably used.
- the surface treatment agent is not particularly limited, but is widely used in the cosmetics field, for example, silicones such as dimethicone and alkyl-modified silicones, alkoxysilanes such as octylriethoxysilane, and dextrin fatty acid esters such as dextrin palmitate. Fatty acids such as stearic acid can be used.
- the component (B) in the present invention includes an embodiment consisting of only an ultraviolet absorber, an embodiment consisting only of an ultraviolet scattering agent, and an embodiment containing both an ultraviolet absorber and an ultraviolet scattering agent.
- the blending amount of the component (B) in the cosmetic of the present invention is not particularly limited, but is preferably 5 to 40% by mass, more preferably 10 to 30% by mass, still more preferably 10 to 20% by mass, based on the total amount of the cosmetic. It is mass%. If the blending amount of the component (B) is less than 5% by mass, it may be difficult to obtain a sufficient UV protection effect, and even if the blending amount exceeds 40% by mass, an increase in the UV protection effect commensurate with the blending amount cannot be expected. Moreover, it is not preferable because the emulsion stability may be deteriorated.
- the cosmetic of the present invention having such a structure has a property that the ultraviolet protection effect (absorbance) is improved when it comes into contact with moisture.
- the UV protection effect (absorbance) is improved by contact with moisture can be roughly defined as follows. A predetermined amount of a sample of emulsified cosmetic is dropped onto a measuring plate, applied to a predetermined area, and dried to form a coating film. The absorbance of the coating film is measured by a spectrophotometer or the like, and the absorbance of the coating film (before a water bath) is taken as an integrated absorbance value (Abs before ) based on the absorbance of the coating film of a substance (for example, glycerin) that does not absorb ultraviolet rays.
- a substance for example, glycerin
- the measuring plate on which the coating film is formed is immersed in water under predetermined conditions, dried, and then the integrated absorbance value (Abs after ) of the coating film (after a water bath) is measured in the same manner.
- the Abs change rate is at least 100% or more, preferably 105% or more, more preferably 110% or more, further preferably 115% or more, and particularly preferably 120% or more.
- component (C) oil phase thickener
- component (C) oil phase thickener
- the UV protection ability of the component (A) of the present invention is synergistically improved.
- the component (C) used in the cosmetic of the present invention is not particularly limited, but is used as a component that exerts an effect of thickening the oil phase by dissolving in oil or swelling with oil in emulsified cosmetics and the like. You can select from the substances you have. Specific examples include dextrin fatty acid esters such as dextrin palmitic acid and dextrin myristic acid; sucrose fatty acid esters such as sucrose caprylic acid ester; 8 solid carbon atoms at room temperature such as lauric acid, myristic acid, palmitic acid, and stearic acid.
- organically modified clay minerals such as disteardimonium hectrite and benzyldimethylstearylammonium hectrite can be mentioned. Of these, it is preferable to use any one or a combination of two or more of organically modified clay minerals, dextrin fatty acid esters and sucrose fatty acid esters.
- the blending amount of the component (C) in the cosmetic of the present invention is not particularly limited, but is preferably 0.1 to 3% by mass, more preferably 0.3 to 1% by mass, based on the total amount of the cosmetic. As the blending amount of the component (C) increases, stickiness tends to occur.
- the cosmetic of the present invention contains oil and water constituting the water-in-oil emulsified skin cosmetic, and if necessary, a surfactant (emulsifier) is added.
- the surfactant used in the cosmetic of the present invention is not particularly limited as long as it is usually used in water-in-oil emulsified cosmetics, but has a silicone skeleton (polysiloxane structure) from the viewpoint of usability.
- a surfactant having an HLB of less than 8 is preferable.
- the blending amount of the surfactant is not particularly limited, but is preferably 0.1 to 10% by mass, more preferably 0.5 to 5% by mass, based on the total amount of the cosmetic.
- the oil content used in the cosmetic of the present invention is not particularly limited, and is, for example, liquid fats and oils such as avocado oil, camellia oil, macadamia nut oil, minced oil, olive oil, castor oil, jojoba oil, triglycerin, and glycerin trioctanoate; Hydrocarbon oils such as paraffin, squalane, paraffin, selecin, squalane; higher grades such as lauric acid, myristic acid, palmitic acid, stearic acid, bechenic acid, oleic acid, 12-hydroxystearic acid, isostearic acid, linoleic acid, linoleic acid.
- liquid fats and oils such as avocado oil, camellia oil, macadamia nut oil, minced oil, olive oil, castor oil, jojoba oil, triglycerin, and glycerin trioctanoate
- Hydrocarbon oils such as paraffin, squalane, par
- Fatty acids Fatty acids; higher alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, oleyl alcohol, monostearyl glycerol ether, monopalmityl glycerol ether, cholesterol, phytosterol, isostearyl alcohol; isononyl isononanoate, isopropyl myristate, cetyl octanoate , Octyldodecyl myristate, butyl stearate, decyl oleate, ethylene glycol dioctanoate, diisostearyl malate, trimethylolpropane trioctanoate, trimethylolpropane triisostearate, pentaerythritol tetraoctanoate, glycerin trioctanoate, triisosteare Ester oils such as glycerin acid, ethyl acetate, butyl a
- the blending amount of the oil is not particularly limited, but is preferably 10 to 70% by mass, more preferably 15 to 70% by mass, and further preferably 20 to 70% by mass with respect to the total amount of cosmetics. By containing the oil content in such a range, it spreads well and is excellent in water resistance and usability.
- Ion-exchanged water or purified water is preferably used as the water used in the cosmetics of the present invention.
- the water content is appropriately determined, but is preferably 1 to 30% by mass with respect to the total amount of the cosmetic.
- the cosmetics of the present invention include components usually used in cosmetics, such as moisturizers, film agents, aqueous phase thickeners, alcohols, chelating agents, coloring materials, pigments, pearl agents, and antioxidants.
- Cosmetics such as moisturizers, film agents, aqueous phase thickeners, alcohols, chelating agents, coloring materials, pigments, pearl agents, and antioxidants.
- Antioxidant antioxidant
- fragrance various medicinal ingredients, preservatives and the like can be appropriately blended as needed.
- the cosmetic of the present invention can be produced according to a method conventionally used for producing a water-in-oil emulsion.
- the water-in-oil emulsified skin cosmetic of the present invention can be obtained by separately preparing an aqueous phase component and an oil phase component, then mixing these aqueous and oil phases and emulsifying them with a homomixer or the like. ..
- the specific dosage form of the cosmetic of the present invention is not particularly limited, but may be a lotion, a milky lotion, a cream, a lotion, a spray, or the like, which exerts a sunscreen effect that improves after bathing.
- the cosmetic of the present invention can be produced by using a conventional method suitable for each dosage form.
- the present invention will be described in more detail with reference to Examples below, but the present invention is not limited thereto.
- the blending amount indicates the mass% with respect to the total amount of cosmetics.
- Abs change rate [(Abs after ) / (Abs before )] ⁇ 100
- Examples 1 and 2 and Comparative Example 1 Water-in-oil emulsified skin cosmetics having the compositions shown in Table 1 below were prepared according to a conventional method. The effect of improving the UV protection ability was evaluated according to the above evaluation method. The results are also shown in the table.
- Examples 3 to 6 and Comparative Example 2 Water-in-oil emulsified skin cosmetics having the compositions shown in Table 2 below were prepared according to a conventional method. According to the above evaluation method, the effect of improving the UV protection ability and the feeling of use were evaluated. In addition, in evaluating the usability, Comparative Example 2 was used as a control. The results are also shown in the table.
- Comparative Example 2 contains disteardimonium hectorite, which is listed in Patent Document 1 as a component having an effect of improving the UV protection ability after bathing. Therefore, it has the effect of improving the UV protection ability after bathing.
- the component (A) of the present invention was blended and further disteardimonium hectorite was added (Examples 3 to 6)
- the effect of improving the ultraviolet protection ability after bathing was increased as compared with Comparative Example 2.
- stickiness was suppressed as compared with Comparative Example 2, and the feeling of use was extremely good.
- Example 7 and Comparative Example 3 Water-in-oil emulsified skin cosmetics having the compositions shown in Table 3 below were prepared according to a conventional method. The effect of improving the UV protection ability was evaluated according to the above evaluation method. The results are also shown in the table.
- Example 7 When the component (A) of the present invention and the oil phase thickener (component (C)) are combined and blended (Example 7), the effect of improving the UV protection ability after a water bath can be obtained by using only the component (A) of the present invention. Comparison was made between the case of containing (Example 1) and the case of containing only the component (C) (Comparative Example 3). As is clear from the results shown in Table 3, it was confirmed that the increase in the UV protection ability improving effect after the water bath by the combination of the component (A) and the component (C) is synergistic.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
(A)(a-1)シラノール基と、オキシプロピレン基(PO)又はオキシエチレン基(EO)とを有するコポリマー、及び
(a-2)シリル化ペプチド、から選択される少なくとも一種;及び
(B)紫外線防御剤を含む油中水型乳化皮膚化粧料を提供する。
(A)(a-1)シラノール基と、オキシプロピレン基(PO)又はオキシエチレン基(EO)とを有するコポリマー及び/又は(a-2)シリル化ペプチド、及び、
(B)紫外線防御剤を必須成分として含むことを特徴とする。
本発明の化粧料を構成する各成分について、以下に詳述する。
下記の一般式(II):
下記の一般式(III)
水浴前後の吸光度の変化率(Abs変化率)を以下の式に従って計算する。
Abs変化率(%)=[(Absafter)/(Absbefore)]×100
Abs変化率が100%を超えた場合に、紫外線防御効果が向上したものと定義する。
測定プレート(Sプレート)(5×5cmのV溝PMMA板、SPFMASTER-PA01)に各例の化粧料(サンプル)を2mg/cm2の量で滴下し、60秒間指で塗布し、15分間乾燥した後に形成された塗膜の吸光度を株式会社日立製作所製U-3500型自記録分光光度計にて測定した。紫外線吸収のないグリセリンをコントロールとし、吸光度(Abs)を以下の式で算出し、280nm~400nmにおける測定値を積算し、吸光度積算値を求めた。
Abs=-log(T/To)
T:サンプルの透過率、To:グリセリンの透過率
測定したプレートを硬度50~500の水に十分に浸し、30分間そのまま水中で撹拌した(3-1モーターで300rpm)。その後、表面の水滴がなくなるまで15~30分程度乾燥させ、再び吸光度を測定し、上記と同様に吸光度積算値を求めた。
紫外線防御能向上効果:
Abs変化率(%)=[(Absafter)/(Absbefore)]×100
各サンプルを、10名の専門パネルに実際に使用してもらい、使用感(べたつきのなさ)について、下記評価基準に従って、4段階で官能評価を行った。
「評価基準」
A:コントロールと比べて非常にべたつきがない。
B:コントロールと比べてべたつきがない。
C:コントロールと同等のべたつきがある。
D:コントロールと比べてべたつきがある。
以下の表1に記載の組成を有する油中水型乳化皮膚化粧料を常法に従って調製した。上記評価方法に従って、紫外線防御能向上効果を評価した。その結果を表に併せて示す。
以下の表2に記載の組成を有する油中水型乳化皮膚化粧料を常法に従って調製した。上記評価方法に従って、紫外線防御能向上効果及び使用感を評価した。なお、使用感の評価にあたり、比較例2をコントロールとして用いた。それらの結果を表に併せて示す。
以下の表3に記載の組成を有する油中水型乳化皮膚化粧料を常法に従って調製した。上記評価方法に従って、紫外線防御能向上効果を評価した。その結果を表に併せて示す。
Claims (5)
- (A)(a-1)シラノール基と、オキシプロピレン基(PO)又はオキシエチレン基(EO)とを有するコポリマー、及び
(a-2)シリル化ペプチド、から選択される少なくとも一種;及び
(B)紫外線防御剤を含む油中水型乳化皮膚化粧料。 - 前記(a-1)コポリマーが主鎖にポリシロキサン構造及びポリオキシアルキレン構造を含み、トリアルコキシシラン基又はシラノール基を有する側鎖を持つコポリマーである、請求項1に記載の油中水型乳化皮膚化粧料。
- 前記(a-2)シリル化ペプチドが、N-[2-ヒドロキシ-3-(3-トリヒドロキシシリル)プロポキシ]プロピル加水分解タンパク又はN-[2-ヒドロキシ-3-(3-ジヒドロキシメチルシリル)プロポキシ]プロピル加水分解タンパクである、請求項1に記載の油中水型乳化皮膚化粧料。
- 前記成分(A)の配合量が0.08~2質量%である、請求項1から3のいずれか一項に記載の油中水型乳化皮膚化粧料。
- (C)油相増粘剤を更に含む、請求項1から4のいずれか一項に記載の油中水型乳化皮膚化粧料。
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202080089492.XA CN114867461B (zh) | 2019-12-24 | 2020-12-10 | 油包水型乳化皮肤化妆品 |
| EP20906957.4A EP4082625A4 (en) | 2019-12-24 | 2020-12-10 | COSMETIC PREPARATION WITH WATER-IN-OIL EMULSION FOR THE SKIN |
| US17/788,565 US12440429B2 (en) | 2019-12-24 | 2020-12-10 | Water-in-oil emulsion cosmetic preparation for skin |
| JP2021567199A JP7760378B2 (ja) | 2019-12-24 | 2020-12-10 | 油中水型乳化皮膚化粧料 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019-233178 | 2019-12-24 | ||
| JP2019233178 | 2019-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2021131720A1 true WO2021131720A1 (ja) | 2021-07-01 |
Family
ID=76575460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2020/045950 Ceased WO2021131720A1 (ja) | 2019-12-24 | 2020-12-10 | 油中水型乳化皮膚化粧料 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12440429B2 (ja) |
| EP (1) | EP4082625A4 (ja) |
| JP (1) | JP7760378B2 (ja) |
| CN (1) | CN114867461B (ja) |
| WO (1) | WO2021131720A1 (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021098688A (ja) * | 2019-12-23 | 2021-07-01 | 花王株式会社 | 毛髪化粧料 |
| US20230071863A1 (en) * | 2021-08-31 | 2023-03-09 | L'oreal | Mineral sunscreen spray |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10194945A (ja) * | 1997-01-06 | 1998-07-28 | Pola Chem Ind Inc | 紫外線防護料 |
| JP2004224757A (ja) * | 2003-01-24 | 2004-08-12 | Kao Corp | 油中水型乳化化粧料 |
| JP2008019248A (ja) * | 2006-06-12 | 2008-01-31 | Seiwa Kasei Co Ltd | 微小カプセルの油性物質分散液、内包済微小カプセルの油性物質分散液及びそれらを含有する化粧料 |
| JP2011503059A (ja) * | 2007-11-02 | 2011-01-27 | モメンティブ パフォーマンス マテリアルズ インコーポレイテッド | エポキシ化合物とアミノシランの反応産物を含有するパーソナルケア組成物 |
| JP2015083561A (ja) * | 2013-09-17 | 2015-04-30 | ロート製薬株式会社 | 皮膚外用剤 |
| WO2016068300A1 (ja) | 2014-10-31 | 2016-05-06 | 株式会社 資生堂 | 日焼け止め化粧料 |
| JP2017066107A (ja) * | 2015-09-30 | 2017-04-06 | 株式会社東洋新薬 | 皮膚外用組成物および紫外線防護化粧料 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE396704T1 (de) | 2004-07-02 | 2008-06-15 | Johnson & Johnson Consumer Fr | Silikon-modifiziertes protein enthaltende sonnenschutzzubereitung |
| KR20080073753A (ko) * | 2005-11-24 | 2008-08-11 | 가부시키가이샤 시세이도 | 피부 외용제 |
| CA2620490C (en) | 2007-10-04 | 2016-06-28 | Genesis Technical Systems Corp. | Remote powering of dsl adms |
| US8642022B2 (en) | 2007-11-02 | 2014-02-04 | Momentive Performance Materials Inc. | Copolymers of epoxy compounds and amino silanes |
| JP5122999B2 (ja) * | 2008-02-15 | 2013-01-16 | 株式会社コーセー | 油中水型日焼け止め化粧料 |
| JP5382904B2 (ja) | 2008-02-19 | 2014-01-08 | 株式会社 資生堂 | 油中水型乳化日焼け止め化粧料 |
| JP5149886B2 (ja) | 2009-11-25 | 2013-02-20 | 花王株式会社 | W/o型乳化化粧料 |
| JP5058352B2 (ja) | 2010-04-13 | 2012-10-24 | 株式会社 資生堂 | 油中水型乳化組成物 |
| JP5361089B2 (ja) | 2011-08-26 | 2013-12-04 | 株式会社 資生堂 | 油中水型乳化日焼け止め化粧料 |
| JP6474744B2 (ja) | 2016-01-29 | 2019-02-27 | 株式会社ナリス化粧品 | 油中水型乳化化粧料 |
| EP3449902A4 (en) | 2016-04-28 | 2019-12-25 | Shiseido Company Ltd. | COSMETIC IN THE FORM OF A WATER-IN-OIL EMULSION |
| JP6881353B2 (ja) | 2017-03-17 | 2021-06-02 | 信越化学工業株式会社 | 有機基変性有機ケイ素樹脂及びその製造方法、ならびに化粧料 |
| JP7563880B2 (ja) | 2017-06-08 | 2024-10-08 | 株式会社 資生堂 | 油中水型乳化化粧料 |
| CN113164792A (zh) * | 2018-11-02 | 2021-07-23 | 西姆莱斯股份公司 | Uv滤光剂的液态透明混合物 |
-
2020
- 2020-12-10 CN CN202080089492.XA patent/CN114867461B/zh active Active
- 2020-12-10 JP JP2021567199A patent/JP7760378B2/ja active Active
- 2020-12-10 WO PCT/JP2020/045950 patent/WO2021131720A1/ja not_active Ceased
- 2020-12-10 US US17/788,565 patent/US12440429B2/en active Active
- 2020-12-10 EP EP20906957.4A patent/EP4082625A4/en not_active Withdrawn
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10194945A (ja) * | 1997-01-06 | 1998-07-28 | Pola Chem Ind Inc | 紫外線防護料 |
| JP2004224757A (ja) * | 2003-01-24 | 2004-08-12 | Kao Corp | 油中水型乳化化粧料 |
| JP2008019248A (ja) * | 2006-06-12 | 2008-01-31 | Seiwa Kasei Co Ltd | 微小カプセルの油性物質分散液、内包済微小カプセルの油性物質分散液及びそれらを含有する化粧料 |
| JP2011503059A (ja) * | 2007-11-02 | 2011-01-27 | モメンティブ パフォーマンス マテリアルズ インコーポレイテッド | エポキシ化合物とアミノシランの反応産物を含有するパーソナルケア組成物 |
| JP2015083561A (ja) * | 2013-09-17 | 2015-04-30 | ロート製薬株式会社 | 皮膚外用剤 |
| WO2016068300A1 (ja) | 2014-10-31 | 2016-05-06 | 株式会社 資生堂 | 日焼け止め化粧料 |
| JP2017066107A (ja) * | 2015-09-30 | 2017-04-06 | 株式会社東洋新薬 | 皮膚外用組成物および紫外線防護化粧料 |
Non-Patent Citations (2)
| Title |
|---|
| "Shin-keshohingaku", 2001, NANZANDO, pages: 497 - 504 |
| See also references of EP4082625A4 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021098688A (ja) * | 2019-12-23 | 2021-07-01 | 花王株式会社 | 毛髪化粧料 |
| JP7744126B2 (ja) | 2019-12-23 | 2025-09-25 | 花王株式会社 | 毛髪化粧料 |
| US20230071863A1 (en) * | 2021-08-31 | 2023-03-09 | L'oreal | Mineral sunscreen spray |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114867461A (zh) | 2022-08-05 |
| EP4082625A1 (en) | 2022-11-02 |
| JP7760378B2 (ja) | 2025-10-27 |
| US20230050910A1 (en) | 2023-02-16 |
| JPWO2021131720A1 (ja) | 2021-07-01 |
| US12440429B2 (en) | 2025-10-14 |
| CN114867461B (zh) | 2025-09-19 |
| EP4082625A4 (en) | 2024-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102791249B (zh) | 油包水型乳化防晒化妆品 | |
| JP6092900B2 (ja) | Uv複合体を含む日焼け止め剤組成物 | |
| JP7794887B2 (ja) | 乳化化粧料 | |
| JP7794886B2 (ja) | 乳化化粧料 | |
| JP7681088B2 (ja) | 化粧料 | |
| JP2011126832A (ja) | 油中水型乳化日焼け止め化粧料 | |
| JP7351837B2 (ja) | 油性化粧料 | |
| KR20190056402A (ko) | 폴리다틴을 포함하는 마이크로에멀젼 조성물 및 사용 방법 | |
| JP7760378B2 (ja) | 油中水型乳化皮膚化粧料 | |
| EP3547990A1 (en) | Sunscreen composition comprising nanocrystalline cellulose | |
| CN108289805B (zh) | 包含疏水改性菊粉和聚醚改性硅氧烷的组合物 | |
| JP7368360B2 (ja) | 化粧料 | |
| WO2022020914A1 (en) | Cosmetic sunscreen composition, process for manufacturing a cosmetic sunscreen composition and use of a cosmetic sunscreen composition | |
| JP7607420B2 (ja) | 水中油型乳化組成物 | |
| CA2298133A1 (en) | Cosmetic light screening composition | |
| EP4667510A1 (en) | Carboxy group-modified organopolysiloxane having (poly)glycerol group or polyoxyalkylene group, and cosmetic preparation | |
| JP2025018346A (ja) | 油中水型乳化化粧料 | |
| JP2026002640A (ja) | 水中油型化粧料 | |
| WO2023218971A1 (ja) | 油中水型日焼け止め化粧料 | |
| EP3903887A1 (en) | External skin preparation | |
| HK1183811A (en) | Water-in-oil emulsified cosmetic preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20906957 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2021567199 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2020906957 Country of ref document: EP Effective date: 20220725 |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 2020906957 Country of ref document: EP |
|
| WWG | Wipo information: grant in national office |
Ref document number: 202080089492.X Country of ref document: CN |
|
| WWG | Wipo information: grant in national office |
Ref document number: 17788565 Country of ref document: US |





